Company profile
Stryker Corporation
NYSE: SYK · Healthcare · Medical - Devices
#23 of 1,422 Healthcare companies by revenuetop-decile growth
EA Score
87AFH 85DQ 97GM 68SS 99
v0.1 · 65/100 weight · provisional
↑ market scale, listing tenure · ↓ growth stability, balance-sheet leverage
Methodology →Revenue TTM
$25.3B
Rev growth YoY (TTM)
+8.8%
Net income (FY)
$3.2B
Employees
56,000
as of 2026-08-04
Market cap
$130.8B
as of 2026-08-04
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$25.1B$25.1B2025
Net income$3.2B$3.2B2025
Operating income$4.9B$4.9B2025
Total assets$47.8B$47.8B2025
Liabilities$25.4B$25.4B2025
Equity$22.4B$22.4B2025
Revenue trend
FY2024 – FY2025 · USD
FY24
FY24
FY24
FY24
FY25
FY25
FY25
FY25
Revenue by segment
Filed disclosures · FY2025
By product
MedSurg62%
Orthopaedics38%
By geography
EMEA52%
Asia Pacific35%
Other foreign countries13%
The read
What is Stryker Corporation’s revenue?
Stryker Corporation booked $25.1B in FY2025 revenue, growing 315% year over year — faster than 92% of Healthcare companies we track, at a 12.9% net margin.
Peers · Healthcare
Medtronic plc84B+Gilead Sciences, Inc.87AMedline Inc.62CDanaher Corporation87ABecton, Dickinson and Company84B+Tenet Healthcare Corporation78B+Key facts
CEOKevin A. Lobo
SectorHealthcare
IndustryMedical - Devices
HeadquartersPortage, MI
ExchangeNYSE: SYK
Employees56,000
IPO date1980-03-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.